Skip to main content
. 2013 Feb 8;5(4):1019–1024. doi: 10.3892/etm.2013.954

Table II.

Neuropsychologic test scores at baseline and follow-up.

CAS group (n=144)
Control group (n=64)
Test Baseline 6 months after stenting P-value Baseline 6 months after medication P-value
MMSE 24.6±1.7 24.8±1.9 0.016 24.7±1.5 24.5±1.6 0.137
MOCA 23.7±1.7 24.1±2.0 0.006 23.8±1.5 23.6±1.8 0.129
FOME 13.8±2.2 14.0±2.3 0.031 14.2±2.3 14.1±2.5 0.171
RVR 25.7±2.1 25.9±2.3 0.201 26.0±1.9 25.8±2.0 0.144
WAIS-DS 6.7±2.1 6.9±2.3 0.040 6.8±2.0 6.6±1.9 0.158
ADL 23.0±2.7 22.9±2.6 0.239 23.1±2.8 23.0±2.6 0.591
NIHSS 0.72±1.16 0.67±1.05 0.294 0.69±1.15 0.63±1.00 0.415

CAS, carotid artery stenting; NIHSS, National Institutes of Health Stroke Scale; ADL, Activities of Daily Living; MMSE, Mini-Mental State Examination; MOCA, Montreal Cognitive Assessment; FOME, Fuld Object Memory Evaluation; RVR, rapid verbal retrieval; WAIS-DS, Wechsler Adult Intelligence Scale-digital span. Values are presented as mean ± standard deviation (SD).